Crestwood Advisors Group’s Viatris VTRS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$433K Buy
27,252
+6,473
+31% +$100K 0.01% 543
2026
Q1
$281K Buy
20,779
+2,075
+11% +$29K ﹤0.01% 608
2025
Q4
$233K Buy
18,704
+213
+1% +$2.3K ﹤0.01% 613
2025
Q3
$183K Buy
18,491
+3,104
+20% +$30.2K ﹤0.01% 557
2025
Q2
$137K Buy
15,387
+4,718
+44% +$39.9K ﹤0.01% 522
2025
Q1
$92.9K Buy
+10,669
New +$112K ﹤0.01% 491
2017
Q2
Sell
-120
Closed -$5K 427
2017
Q1
$5K Buy
+120
New +$4.84K ﹤0.01% 481
2015
Q2
Sell
-4,450
Closed -$264K 165
2015
Q1
$264K Buy
+4,450
New +$254K 0.04% 118

Other funds holding VTRS

Crestwood Advisors Group's VTRS Position: Q2 2026 in Review

Crestwood Advisors Group increased its Viatris (VTRS) stake by 31% in Q2 2026, buying an estimated $100K and bringing the position to 27,252 shares worth $433K. The position accounts for 0.01% of the portfolio, ranked #543.

Crestwood Advisors Group first reported a position in VTRS in Q1 2015 and has held it in 8 quarters since. 1,028 funds tracked by Wall St. Rank hold VTRS as of Q2 2026.

  • Crestwood Advisors Group held 27,252 shares of Viatris worth $433K as of Q2 2026.
  • Crestwood Advisors Group bought 6,473 Viatris shares in Q2 2026, an estimated $100K.
  • Viatris made up 0.01% of Crestwood Advisors Group's portfolio in Q2 2026, its #543 holding.
  • Crestwood Advisors Group first reported a position in Viatris in Q1 2015 and has held it in 8 quarters since.
  • 1,028 funds tracked by Wall St. Rank held Viatris as of Q2 2026.

Based on Crestwood Advisors Group's 13F filing for Q2 2026, filed 3 Aug 2026.